Therapy of steroid-resistant inflammatory bowel disease
Data(s) |
2012
|
---|---|
Resumo |
Although systemic corticosteroids are successfully administered for the induction of clinical response and remission in the majority of patients with inflammatory bowel disease (IBD) presenting with a flare, a proportion of these patients demonstrate a primary nonresponse to steroids or in the case of an initial response, they develop a resistance or a steroid dependence. Long-term therapy with corticosteroids for treatment of IBD should be avoided, given the high frequency of adverse treatment effects. Knowledge about treatment strategies in case of steroid nonresponse is therefore highly relevant. |
Formato |
application/pdf |
Identificador |
http://boris.unibe.ch/14034/1/Manz%20Digestion%202012.pdf Manz, Michael; Vavricka, Stephan R; Wanner, Roger; Lakatos, Peter L; Rogler, Gerhard; Frei, Pascal; Safroneeva, Ekaterina; Schoepfer, Alain M (2012). Therapy of steroid-resistant inflammatory bowel disease. Digestion, 86 Suppl 1, pp. 11-15. Basel: Karger 10.1159/000341952 <http://dx.doi.org/10.1159/000341952> doi:10.7892/boris.14034 info:doi:10.1159/000341952 info:pmid:23051721 urn:issn:0012-2823 |
Idioma(s) |
eng |
Publicador |
Karger |
Relação |
http://boris.unibe.ch/14034/ |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Manz, Michael; Vavricka, Stephan R; Wanner, Roger; Lakatos, Peter L; Rogler, Gerhard; Frei, Pascal; Safroneeva, Ekaterina; Schoepfer, Alain M (2012). Therapy of steroid-resistant inflammatory bowel disease. Digestion, 86 Suppl 1, pp. 11-15. Basel: Karger 10.1159/000341952 <http://dx.doi.org/10.1159/000341952> |
Palavras-Chave | #610 Medicine & health |
Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion NonPeerReviewed |